Jaffe E.A., Ruggiero J.T., Leung L.L.D., Doyle M.J., McKeon-Longo P.J., Mosher D.F. (1983) Cultured human fibroblasts synthesize and secrete thrombospondin and incorporate it into extracellular matrix. Natl Acad Sci 80:998-1002.
Jaffe E.A., Ruggiero J.T., Falcon D.J. (1985) Monocytes and macrophages synthesize and secrete thrombospondin. Blood 65:79-84.
Majack R.A., Cook S., Bornstein P. (1985) Platelet-derived growth factor and heparine-like glycosaminoglycans regulate thrombospondin synthesis and deposition in the matrix by smooth muscle cells. J Cell Biol 101:1059-1070.
Varani J., Rister B.L., Hughes L.A., Carey T.E., Fligiel S.E.G., Dixit V.M. (1989) Characterization of thrombospondin synthesis, secretion and cell surface expression by human tumor cells. Clin Exp Metastasis 7:265-276.
Adams J.A. (1997) Thrombospondin-1. Int Biochem Cell Biol 29:861-865.
Bornstein P. (1992) Thrombospondins: Structure and regulation of expression. FASEB J 6:3290-3299.
Oldberg A., Antonsson P., Lindblom K., Heinegard D. (1992) COMP (cartilage oligomeric matrix protein) is structurally related to the thrombospondins. J Bioch Chem 267:22346-22350.
Roberts D.D. (1996) Regulation of tumor growth and metastasis by thrombospondin-1. FASEB J 10:1183-1191.
Weinstat-Saalow D.L., Zabrenetzy V.S., VanHoutte K., Frazier W.A., Roberts D.D., Steeg P.S. (1994) Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis. Cancer Res 54:6504-6511.
Dameron K.M., Volpert O.V., Tiansky M.A., Bouck N. (1994) Control of angiogenesis in fibroblast by p53 regulation of thrombospondin-1. Science 265:1582-1584.
Grant S.W., Kyshtoobayeva A.S., Kurosaki T., Jakowatz J., Fruehauf J.P. (1998) Mutant p53 correlates with reduced expression of thrombospondin-1, increased angiogenesis, and metastatic progression in melanoma. Cancer Detect Prev 22(3):185-194.
Rastinejad F., Polverini P.J., Bouck N.P. (1989) Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell 59:345-355.
Volpert O.V., Tolsma S.S., Pellerin S., Feige J.J., Chen H., Mosher D.F. (1995) Inhibition of angiogenesis by thrombospondin-2. Biochem Biophys Res Commun 217:326-332.
Xu M., Kumar D., Stass S.A., Mixson A.J. (1998) Gene therapy with p53 and a fragment of thrombospondin 1 inhibits human breast cancer in vivo. Mal Genet Metab 63(2):103-109.
Grossfeld G.D., Ginsberg D.A., Stein J.P., Bochner B.H., Esrig D., Groshen S. (1997) Thrombospondin-1 expression in bladder cancer: Association with p53 alteration, tumor angiogenesis, and tumor progression. J Natl Cancer Inst 89:219-227.
Hsu S.C., Volpert O.V., Steck P.A., Mikkelsen T., Polverini P.J., Rao S. (1996) Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1. Cancer Res 56(5684):5691.
Streit M., Velasco P., Brown L.F., Stroke M., Richard M., Riccardi L. (1999) Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas. Am J Pathol 155(2):441-452.
Bornstein P. (1995) Diversity of function is inherent in matricellular proteins: An appraisal of thrombospondin 1. J Cell Biol 130:503-206.
Zabrenetzy V.S., Harris C.C., Steeg P.S., Roberts D.D. (1994) Expression of the extracellular matrix molecule thrombospondin inversly correlates with malignant progression in melanoma, lung and breast carcinoma cell lines. Int J Cancer 59:191-195.
Oshika Y., Masuda K., Tokunaga T., Hatanaka H., Kamiya T., Abe Y. (1998) Thrombospondin 2 gene expression is correlated with decreased vascularity in non-small cell lung cancer. Clin Cancer Res 4:1785-1788.
Fontanini G., Boldrini L., Calcinai A., Chinè S., Lucchi M., Mussi A. (1999) Thrombospondins 1 and 2 messenger RNA expression in lung carcinoma: Relationship with p53 alterations, angiogenic growth factors, and vascular density. Clin Cancer Res 5:155-161.
Parum D.V., Crdell J.L., Micklem K., Heryet A.R., Gatter K.C., Mason D.Y. (1990) JC70: A new monoclonal antibody that detects vascular endothelium associated antigen on routinely proceesed tissue sections. J Clin Pathol 43:752-757.
Key G., Becker M.H., Baron B., Duchrow M., Schüter C., Flad H.D. (1993) New Ki-67-equivalent murine monoclonal antibodies (MIB1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope. Lab Invest 68:629-636.
King G., Payne S., Walker F., Murray G.I. (1997) A highly sensitive detection method for immunohistochemistry using biotinylated thyramine. J Pathol 183:237-241.
Shi S.R., Ky M.E., Kalra K.L. (1991) Antigen retrieval in formalin-fixed paraffin- embedded tissues: An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39(6):741-748.
Liao S.Y., Brewer C., Zavada J., Pastorek J., Pastorekova S., Manetta A. (1994) Identification of the antigen as a diagnostic biomarker of cervical intraepithelial squamous and glandular neoplasia and cervical carcinomas. Am J Pathol 145:598-609.
World H.O. Histological Typing of Lung and Pleural Tumors, 3rd edition, World Health Organization; 1998.
Moutain C.F. (1997) Revisons in the international system for staging lung cancer. Chest 111:1710-1717.
Volm M., Koomägi R., Mattern J. (1999) Angiogenesis and cigarette smoking in squamous cell lung carcinomas: An immunohistochemical study of 28 cases. Anticancer Res 19:333-336.
